1 minute reading time (39 words)

Statement from FDA Commissioner Scott Gottlieb, MD, on Unprecedented New Efforts to Support Development of Over-the-Counter Naloxone to Help Reduce Opioid Overdose Deaths

To encourage drug companies to enter the OTC market and increase access to naloxone, the FDA took an unprecedented step of developing a model Drug Facts label (DFL) with easy-to-understand pictograms on how to use the drug. Full story.

Related Posts

Want more pain resources? Check out our library of on-demand education, upcoming events, and more.

Learn More